These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9363194)

  • 21. Progress towards gene therapy for cystic fibrosis.
    Tate S; Elborn S
    Expert Opin Drug Deliv; 2005 Mar; 2(2):269-80. PubMed ID: 16296753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cystic fibrosis--gene therapy--how long have the patients to wait?].
    Schiøtz PO
    Ugeskr Laeger; 1999 Apr; 161(16):2377. PubMed ID: 10235046
    [No Abstract]   [Full Text] [Related]  

  • 23. [Possibilities and difficulties in gene therapy in pulmonology].
    Zikić T
    Med Pregl; 1997; 50(11-12):487-90. PubMed ID: 9471508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cystic fibrosis].
    Høiby N; Koch C; Frederiksen B
    Nord Med; 1998 Dec; 113(10):328-30. PubMed ID: 9894407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achieving genetic potential for nutrition and growth in cystic fibrosis.
    Shepherd R
    J Pediatr; 2002 Apr; 140(4):393-5. PubMed ID: 12006951
    [No Abstract]   [Full Text] [Related]  

  • 26. Aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    N Engl J Med; 1990 Oct; 323(14):996-8. PubMed ID: 2402269
    [No Abstract]   [Full Text] [Related]  

  • 27. [Other therapeutic aspects of pulmonary disease in cystic fibrosis].
    Navarro M; Argüelles F; Dapena J
    An Esp Pediatr; 1993 Oct; 39 Suppl 55():200-3. PubMed ID: 8291801
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibiotic therapy for pulmonary exacerbations in adults with cystic fibrosis.
    Elpern EH; Patel G; Balk RA
    Medsurg Nurs; 2007 Oct; 16(5):293-8; quiz 299. PubMed ID: 18072667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental paradigm for early features of cystic fibrosis.
    Larson JE; Cohen JC
    Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
    Zhang LN; Karp P; Gerard CJ; Pastor E; Laux D; Munson K; Yan Z; Liu X; Godwin S; Thomas CP; Zabner J; Shi H; Caldwell CW; Peluso R; Carter B; Engelhardt JF
    Mol Ther; 2004 Dec; 10(6):990-1002. PubMed ID: 15564131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cystic fibrosis: from the child to the adult].
    Murris-Espin M; Didier A
    Rev Mal Respir; 2000 Aug; 17(3 Pt 2):721-3. PubMed ID: 11076381
    [No Abstract]   [Full Text] [Related]  

  • 32. The clinical approach to lung disease in patients with cystic fibrosis.
    O'Sullivan BP; Flume P
    Semin Respir Crit Care Med; 2009 Oct; 30(5):505-13. PubMed ID: 19760538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
    Pringle IA; Hyde SC; Gill DR
    Expert Opin Biol Ther; 2009 Aug; 9(8):991-1003. PubMed ID: 19545217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revisiting the mouse lung model for CF.
    Boyd AC; Porteous DJ
    Gene Ther; 2004 May; 11(9):737-8. PubMed ID: 14999230
    [No Abstract]   [Full Text] [Related]  

  • 35. Intensive care management of the patient with cystic fibrosis.
    Kremer TM; Zwerdling RG; Michelson PH; O'Sullivan P
    J Intensive Care Med; 2008; 23(3):159-77. PubMed ID: 18443012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetically engineered bacteria may be useful for delivery of mucolytics into cystic fibrosis lungs.
    Babinec P; Babincová M
    Med Hypotheses; 2006; 67(2):426-7. PubMed ID: 16675156
    [No Abstract]   [Full Text] [Related]  

  • 37. Potential of helper-dependent adenoviral vectors in modulating airway innate immunity.
    Kushwah R; Cao H; Hu J
    Cell Mol Immunol; 2007 Apr; 4(2):81-9. PubMed ID: 17484801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In clinical practice].
    Delaisi B; Gérardin M
    Rev Prat; 2003 Jan; 53(2):171-3. PubMed ID: 12664850
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gene therapy of hereditary diseases].
    Ginter EK
    Vopr Med Khim; 2000; 46(3):265-78. PubMed ID: 11033886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene delivery systems--gene therapy vectors for cystic fibrosis.
    Klink D; Schindelhauer D; Laner A; Tucker T; Bebok Z; Schwiebert EM; Boyd AC; Scholte BJ
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():203-12. PubMed ID: 15463959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.